SCHEMBL5034442

SCHEMBL5034442

CCOc1ccc(CC2(C(=O)O)CCCO2)cc1CNC(=O)c1ccc(C(F)(F)F)cc1F

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.54
PPARA Q07869 16/20 0.54
PPARG P37231 11/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5031896 0.92 PPARD (0.60) PPARDPPARAPPARG
SCHEMBL5031721 0.85 SORT1 (0.44) PPARDPPARAPPARG
SCHEMBL5036999 0.84 PPARD (0.47) PPARDPPARAPPARG
SCHEMBL5032904 0.83 PPARA (0.46) PPARDPPARAPPARG
SCHEMBL5031789 0.82 PPARG (0.47) PPARDPPARAPPARG
SCHEMBL5140591 0.82 PPARG (0.47) PPARDPPARAPPARG
SCHEMBL5139221 0.82 PPARG (0.47) PPARDPPARAPPARG
SCHEMBL5031809 0.82 ALDH1A1 (0.37) PPARDPPARAPPARG
SCHEMBL5139800 0.82 ALDH1A1 (0.37) PPARDPPARAPPARG
SCHEMBL5032880 0.82 HTT (0.46) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-20050014833-A1 Cyclic compound and ppar agonist EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-20 US disclosed
EP-1452521-A1 CYCLIC COMPOUND AND PPAR AGONIST Eisai Co., Ltd. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014833-A1 Cyclic compound and ppar agonist PPARA, PPARG, PPARD PPARD 3/4885PPARA 1/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.